Choate Sponsors BIO IPCC Fall Conference 2013

Choate Event Announcement

 | November 6, 2013


Event: 
Fall Conference and Meeting

Organization:  BIO IP Counsels Committee
Location:  Washington, DC 

 


Choate sponsored a half-day program at the BIO IP Counsels Committee Fall Conference and Meeting, which included the following expert panels moderated by Choate attorneys:

Brenda Jarrell, PhD, chair of Intellectual Property, moderated the panel "Does Myriad Matter?"  which addressed the impact that the Myriad decision has had on patent examination and strategies.  Topics of discussion included:  has the world changed now that "isolated" DNA is officially not patentable?  Are companies changing their IP strategies?  Is the USPTO changing its examination approach?  Has the logic of Myriad been extended to other products of nature (proteins, natural products)? Do the Myriad and Prometheus decisions together create a different value proposition for life sciences IP as contrasted with other industries? Are these decisions even meaningful, given their (necessarily?) simplistic appreciation of the technology?  What should our community do, if anything, to improve the understanding that courts, administrative agencies, and/or Congress have about life sciences technologies?

Eric Marandett, co-chair of IP Litigation, moderated the panel "Is There a New Paradigm for Indirect Infringement?" in which panelists discussed the implications of the changing legal landscape for indirect infringement.  In particular, the Federal Circuit's recent decisions in cases like Akamai v. Limelight and Commil v. Cisco have raised the bar for proving joint infringement and induced infringement.  The panel reviewed the changes in the law articulated by these cases and considered the impact on the value and enforceability of biotech patents.  For example, the panel discussed whether method of use, method of testing and method of manufacture patents still can be followed in developing and enforcing this type of patent in order to minimize the risk.


BIO IPCC serves in-house legal and IP professionals in the biotechnology industry, providing attendees with an opportunity to explore significant current and projected topics in the field.

 

Thank you for reaching out to contact Choate. Before you send your message, we wanted to make sure you are aware of the following. Please do not send any confidential information in response to this link. Sending an e-mail to Choate does not give rise to an attorney-client relationship, and will not be deemed to disqualify Choate from undertaking any engagement for a current or future client.  Before any attorney-client engagement may be formed, Choate will need to check for possible conflicts of interest, you will need to consider whether you wish to retain Choate as counsel, and we will need to consider whether we wish to accept the potential engagement. In the meantime, Choate reserves the right to represent parties with interests adverse to you.

AcceptDecline